123 related articles for article (PubMed ID: 27916068)
1. [The correlation between cerebral MRI characteristics of posterior reversible encephalopathy syndrome and serum levels of PlGF, sEng in patients with pre-eclampsia].
Jiang KM; Zhong X; Tan Y; Liu GC; Mai H; Wu SX
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):840-844. PubMed ID: 27916068
[No Abstract] [Full Text] [Related]
2. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
Gu Y; Lewis DF; Wang Y
J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952
[TBL] [Abstract][Full Text] [Related]
3. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
Aggarwal PK; Chandel N; Jain V; Jha V
J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
[TBL] [Abstract][Full Text] [Related]
4. The Association of IL-17 and PlGF/sENG Ratio in Pre-Eclampsia and Adverse Pregnancy Outcomes.
Darmochwal-Kolarz D; Chara A
Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36613090
[TBL] [Abstract][Full Text] [Related]
5. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic profile and smoking in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort.
Jääskeläinen T; Suomalainen-König S; Hämäläinen E; Pulkki K; Romppanen J; Heinonen S; Laivuori H;
Ann Med; 2017 Nov; 49(7):593-602. PubMed ID: 28537456
[TBL] [Abstract][Full Text] [Related]
7. The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.
Chaiworapongsa T; Romero R; Whitten AE; Korzeniewski SJ; Chaemsaithong P; Hernandez-Andrade E; Yeo L; Hassan SS
J Matern Fetal Neonatal Med; 2016; 29(8):1214-28. PubMed ID: 26303962
[TBL] [Abstract][Full Text] [Related]
8. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
Govender N; Naicker T; Rajakumar A; Moodley J
Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
[TBL] [Abstract][Full Text] [Related]
9. Low placental growth factor levels and high soluble endoglin levels at 26-31 weeks of gestation precede light placenta with and without relatively heavy infant, respectively: A retrospective cohort study.
Hirashima C; Ohkuchi A; Sasaki K; Takahashi K; Suzuki H; Matsubara S; Matsuda Y
J Obstet Gynaecol Res; 2021 Mar; 47(3):1040-1051. PubMed ID: 33401341
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis.
Kleinrouweler CE; Wiegerinck MM; Ris-Stalpers C; Bossuyt PM; van der Post JA; von Dadelszen P; Mol BW; Pajkrt E;
BJOG; 2012 Jun; 119(7):778-87. PubMed ID: 22433027
[TBL] [Abstract][Full Text] [Related]
11. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction.
Nanjo S; Minami S; Mizoguchi M; Yamamoto M; Yahata T; Toujima S; Shiro M; Kobayashi A; Muragaki Y; Ino K
J Obstet Gynaecol Res; 2017 Dec; 43(12):1805-1814. PubMed ID: 28929598
[TBL] [Abstract][Full Text] [Related]
12. Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation.
Savvidou MD; Noori M; Anderson JM; Hingorani AD; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Dec; 32(7):871-6. PubMed ID: 18814185
[TBL] [Abstract][Full Text] [Related]
13. Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.
Ohkuchi A; Hirashima C; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
Hypertens Pregnancy; 2009 Feb; 28(1):95-108. PubMed ID: 19165674
[TBL] [Abstract][Full Text] [Related]
14. Maternal plasma soluble endoglin at 11-13 weeks' gestation in pre-eclampsia.
Foidart JM; Munaut C; Chantraine F; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2010 Jun; 35(6):680-7. PubMed ID: 20205159
[TBL] [Abstract][Full Text] [Related]
15. MRI characteristics of brain edema in preeclampsia/eclampsia patients with posterior reversible encephalopathy syndrome.
Mai H; Liang Z; Chen Z; Liu Z; Xu Y; Chen X; Du X; Peng Y; Chen Y; Dong T
BMC Pregnancy Childbirth; 2021 Oct; 21(1):669. PubMed ID: 34602066
[TBL] [Abstract][Full Text] [Related]
16. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA
Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti-hypertensive drugs on production of soluble fms-like tyrosine kinase 1 and soluble endoglin from human normal and pre-eclamptic placentas in vitro.
Xu B; Thornton C; Tooher J; Ogle R; Lim S; Makris A; Hennessy A
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):839-42. PubMed ID: 19215236
[TBL] [Abstract][Full Text] [Related]
18. Gestational hypertension as a subclinical preeclampsia in view of serum levels of angiogenesis-related factors.
Hirashima C; Ohkuchi A; Takahashi K; Suzuki H; Yoshida M; Ohmaru T; Eguchi K; Ariga H; Matsubara S; Suzuki M
Hypertens Res; 2011 Feb; 34(2):212-7. PubMed ID: 21048778
[TBL] [Abstract][Full Text] [Related]
19. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.
De Vivo A; Baviera G; Giordano D; Todarello G; Corrado F; D'anna R
Acta Obstet Gynecol Scand; 2008; 87(8):837-42. PubMed ID: 18607829
[TBL] [Abstract][Full Text] [Related]
20. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
Leaños-Miranda A; Campos-Galicia I; Berumen-Lechuga MG; Molina-Pérez CJ; García-Paleta Y; Isordia-Salas I; Ramírez-Valenzuela KL
J Rheumatol; 2015 Jul; 42(7):1141-9. PubMed ID: 25979720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
